Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Carcinogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/CARCIN/21.1.1PMID 10607726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA adduct level induced by 2-amino-3,4-dimethylimidazo[4,5-f]-quinoline in Big Blue mice does not correlate with mutagenicity.

  1998cited by this paper
• Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in human lymphoblastoid cells.

  1998cited by this paper
• Transgenic mutation models: Research, testing, and reality checks

  1998cited by this paper
• No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue mice.

  1998cited by this paper
• Mutagenic specificity of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in Escherichia coli using the yeast URA3 gene as a target.

  1998cited by this paper
• Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Blue mouse with those in tumor related genes in rodents.

  1997cited by this paper
• Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene.

  1997cited by this paper
• Formation and differential removal of C-8 and N2-guanine adducts of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in the liver, kidney, and colorectum of the rat.

  1996cited by this paper
• Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals.

  1996cited by this paper
• Organ variation in the mutagenicity of MeIQ in Big Blue lacI transgenic mice.

  1996cited by this paper
• System issues: Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue® mice

  1996cited by this paper
• Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate.

  1996cited by this paper
• In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.

  1996cited by this paper
• Technologies for Detection of DNA Damage and Mutations

  1996cited by this paper
• The Use of lacI Transgenic Mice in Genetic Toxicology

  1996cited by this paper
• Mutational specificity: Spectrum of mutations in kidney, stomach, and liver from lacl transgenic mice recovered after treatment with tris(2,3‐dibromopropyl)phosphate

  1996cited by this paper
• Reality Check

  1996cited by this paper
• Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

  1995cited by this paper
• DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats.

  1995cited by this paper
• Escherichia coli lacZ strains engineered for detection of frameshift mutations induced by aromatic amines and nitroaromatic compounds.

  1995cited by this paper
• Mutational specificity of 2‐amino‐3‐methylimidazo‐[4,5‐f]quinoline in the hprt locus of CHO‐K1 cells

  1995cited by this paper
• The use of shuttle vectors for mutation analysis in transgenic mice and rats.

  1994cited by this paper
• Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system.

  1994cited by this paper
• Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice.

  1994cited by this paper
• Carcinogenic factors in food with relevance to colon cancer development.

  1993cited by this paper
• Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.

  1993cited by this paper
• High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline.

  1993cited by this paper
• Food-derived mutagens and carcinogens.

  1992cited by this paper
• Detection of a Ha-ras point mutation by polymerase chain reaction-single strand conformation polymorphism analysis in 2-amino-3,4-dimethylimidazo[4,5-f]quinoline-induced mouse forestomach tumors.

  1992cited by this paper
• Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.

  1992cited by this paper
• Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine.

  1992cited by this paper
• Carcinogenicities of heterocyclic amines in cooked food.

  1991cited by this paper
• Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

  1991cited by this paper
• Mutational activation of c‐HA‐ras gene in squamous cell carcinomas of rat zymbal gland induced by carcinogenic heterocyclic amines

  1991cited by this paper
• Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector

  1991cited by this paper
• Carcinogenicity of 2‐Amino‐3‐methylimidazo[4,5‐f]quinoline in Nonhuman Primates: Induction of Tumors in Three Macaques

  1990cited by this paper
• Successful use of short-term tests for academic purposes: their use in identification of new environmental carcinogens with possible risk for humans.

  1988cited by this paper
• Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazolo[4,5-f]quinoline with DNA. Synthesis and identification of N-(deoxyguanosin-8-yl)-IQ.

  1988cited by this paper
• Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process.

  1985cited by this paper
• Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract.

  1984cited by this paper
• Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.

  1983cited by this paper
• Activation of carcinogens and mutagens by rat colon mucosa.

  1978cited by this paper

• Mutagenicity of carcinogenic heterocyclic amines in Salmonella typhimurium YG strains and transgenic rodents including gpt delta

  2021cites this paper
• Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD.

  2019cites this paper
• Angiotensin II-induced hypertension increases the mutant frequency in rat kidney

  2019cites this paper
• Green synthesis of pyrimido‐isoquinolines and pyrimido‐quinoline using ZnO nanorods as an efficient catalyst: Study of antioxidant activity

  2018cites this paper
• Organo-Sulphur Garlic Compounds Influence Viability of Mammalian Cells: A Review

  2018cites this paper
• Transgenic rat models for mutagenesis and carcinogenesis

  2017cites this paper
• Longevity: epigenetic and biomolecular aspects

  2015cites this paper
• Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice

  2014cites this paper
• Synthesis and biological activity of pyrimido [1, 2-a] quinoline moiety and its 2-substituted derivatives

  2013cites this paper
• Synthesis and Antimicrobial Activity of 3-Cyano-4-imino-9-methoxy-4H-pyrimido [2, 1-b] pyrimido [4, 5-b] quinoline and 2-Substituted Derivatives

  2013cites this paper
• Dammar resin, a non-mutagen, induces [corrected] oxidative stress and metabolic enzymes in the liver of gpt delta transgenic mouse which is different from a mutagen, 2-amino-3-methylimidazo[4,5-f]quinoline.

  2012cites this paper
• Synthesis of Some Pyrimido[4,5-b]quinoline Derivatives.

  2011cites this paper
• Heterocyclic Aromatic Amines: Potential Human Carcinogens

  2011cites this paper
• Chapter 2 – Heterocyclic Aromatic Amines: Potential Human Carcinogens

  2010cites this paper
• Aromatic Amines and Heterocyclic Aromatic Amines: From Tobacco Smoke to Food Mutagens

  2010cites this paper
• Heterocyclic Aromatic Amines

  2008cites this paper
• Mass spectrometric investigation of the sequence selectivity for adduction of heterocyclic aromatic amines on single-strand oligonucleotides.

  2008cites this paper
• Biochemical Basis of Genotoxicity of Heterocyclic Arylamine Food Mutagens

  2006cites this paper
• Transgenic animal mutagenicity assays

  2006cites this paper
• GSTM1 and GSTT1 Polymorphisms, Cigarette Smoking, and Risk of Colon Cancer: A Population-based Case-control Study in North Carolina (United States)

  2006cites this paper
• TRANSGENIC ANIMAL MUTAGENICITY ASSAYS

  2006cites this paper
• In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N‐nitrosopyrrolidine, 2‐amino‐3‐methylimidazo[4,5‐f]quinoline, and di(2‐ethylhexyl)phthalate

  2005cites this paper
• Detailed review of transgenic rodent mutation assays.

  2005cites this paper
• Synthesis and Spectroscopic Properties of Some Pyrimido(4,5-b)quinoline Derivatives

  2005cites this paper
• Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens

  2005cites this paper
• Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis.

  2005cites this paper
• Sucrose and IQ induced mutations in rat colon by independent mechanism.

  2004cites this paper
• PASSCLAIM1—Diet-related cancer

  2004cites this paper
• Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.

  2003cites this paper
• Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis.

  2003influential citation
• Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice.

  2003cites this paper
• Effect of increased intake of dietary animal fat and fat energy on oxidative damage, mutation frequency, DNA adduct level and DNA repair in rat colon and liver.

  2003cites this paper
• Low dose genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in gpt delta transgenic mice.

  2003cites this paper
• Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models.

  2002cites this paper
• Mutation spectrum of 1,2-dibromo-3-chloropropane, an endocrine disruptor, in the lacI transgenic Big Blue Rat2 fibroblast cell line.

  2002cites this paper
• Mutagenicity of Food-Derived Carcinogens and the Effect of Antioxidant Vitamins

  2002cites this paper
• Mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in colon and liver of Big Blue rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress.

  2002cites this paper
• One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene.

  2002cites this paper
• HETEROCYCLIC AROMATIC AMINE METABOLISM, DNA ADDUCT FORMATION, MUTAGENESIS, AND CARCINOGENESIS

  2002cites this paper
• Sex‐specific induction of mutations by PhIP in the kidney of male and female rats and its modulation by conjugated linoleic acid

  2002cites this paper
• Recent advances in the protocols of transgenic mouse mutation assays.

  2000cites this paper
• Strategies and testing methods for identifying mutagenic risks.

  2000cites this paper
• Mutant frequency and molecular analysis of in vivo lacI mutations in the bone marrow of Big Blue® rats treated with 7,12‐dimethylbenz[a]anthracene

  2000cites this paper